Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Inovio Has 'Bigger Value Drivers' Outside Of COVID-19 Vaccine Program: BofA Analyst
12:11pm, Tuesday, 23'rd Mar 2021
Inovio Pharmaceuticals, Inc. (NASDAQ: INO), which has fallen behind in the COVID-19 vaccine race, has much to offer beyond a coronavirus vaccine, according to a BofA Securities analyst. The Inovio
DraftKings, GlaxoSmithKline, Netflix, Southwest and More Tuesday Afternoon Analyst Calls
11:48am, Tuesday, 23'rd Mar 2021
With the trading day about halfway over, the broad markets had pulled back slightly.
Vaxart or Inovio: Which Is More Likely to Double Your Money?
08:00am, Sunday, 21'st Mar 2021
Let's look at what some of the smartest investors are saying.
These 3 Vaccine Stocks May Be Post-Pandemic Winners
06:00am, Saturday, 20'th Mar 2021
Why? They're focusing on one of the biggest coronavirus problems.
4 Heavily Short-Sold Stocks to Avoid Like the Plague
06:06am, Tuesday, 16'th Mar 2021
Although these stocks are popular with the Reddit community, they're bad news.
Can Inovio Pharmaceuticals Stock Recover After The Recent 25% Drop?
09:00am, Thursday, 04'th Mar 2021
The stock price of Inovio Pharmaceuticals, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large 27% drop over the last ten trading d
Why Inovio Stock Is Tanking Today
11:27am, Tuesday, 02'nd Mar 2021
Investors still appear to have doubts about two of the biotech's lead candidates.
Why Inovio's Positive Q4 Update Didn't Impress Investors
06:02am, Tuesday, 02'nd Mar 2021
Better-than-expected top- and bottom-line results weren't enough.
Inovio Pharmaceuticals' (INO) CEO Joseph Kim on Q4 2020 Results - Earnings Call Transcript
01:13am, Tuesday, 02'nd Mar 2021
Inovio Pharmaceuticals' (INO) CEO Joseph Kim on Q4 2020 Results - Earnings Call Transcript
Inovio Reports Q4 Earnings Beat, Mixed REVEAL 1 Data And Coronavirus Vaccine Update
05:00pm, Monday, 01'st Mar 2021
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are lower in after-hours trading in reaction to multiple catalysts. REVEAL 1 Study Reveals Mixed Results In Cervical Dysplasia: Inovio said a pivotal R
Recap: Inovio Pharmaceuticals Q4 Earnings
04:35pm, Monday, 01'st Mar 2021
Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 63.16% over the past year to (
Earnings Outlook For Inovio Pharmaceuticals
10:09am, Friday, 26'th Feb 2021
On Monday, March 01, Inovio Pharmaceuticals (NASDAQ:INO) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.
Is a Surprise Coming for Inovio (INO) This Earnings Season?
09:51am, Friday, 26'th Feb 2021
Inovio (INO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Qiagen, Inovio In Development Pact For VGX-3100 Companion Diagnostics
07:26am, Wednesday, 24'th Feb 2021
Qiagen NV (NYSE: QGEN) and Inovio Pharmaceuticals Inc (NASDAQ: INO) expanded their partnership with a new master collaboration agreement to develop liquid biopsy-based companion diagnostic prod
PLYMOUTH MEETING, Pa. and GERMANTOWN, Md. and HILDEN, Germany, Feb. 24, 2021 /PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced
